Tags

gram-negative non-fermentative bacteria

metallo-β-lactamases (MβL)

chronic pathologic process

cost of illness

discounting

formulary development process

pharmacoeconomical study

medications

group A betahemolytic streptococcus

invasive aspergillosis; сaspofungin; antifungal drugs